Pei‐Chi Kao

Statistics

Publications

Citations

412

H-Index

Active since

2005

Affiliations

Dana-Farber/Boston Children's Cancer and Blood Disorders Center(Current)

Harvard University

Boston Children's Hospital

Dana-Farber Cancer Institute

Massachusetts General Hospital

Pei‐Chi Kao is an author at Dana-Farber/Boston Children's Cancer and Blood Disorders Center specializing in medicine, oncology, and molecular oncology.

Publications per year

2005–2023

Publications

RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma

Huey‐Huey Chua, Daw‐Jen Tsuei, Po‐Huang Lee et al. · Hepatology · 2015 · 65 citations

Medicine, Molecular Biology, Oncology +17

Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer

Alanna J. Church, Laura Corson, Pei‐Chi Kao et al. · Nature Medicine · 2022 · 65 citations · Full text

Medicine, Molecular Biology, Oncology +14

Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort

Michelle Long Schoettler, Leslie Lehmann, Steven Margossian et al. · Blood Advances · 2020 · 52 citations · Full text

Medicine, Hematology, Pediatrics +12

A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade glioma

Karen Wright, Xiaopan Yao, Wendy B. London et al. · Pediatric Blood & Cancer · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma

David S. Shulman, Priscilla Merriam, Edwin Choy et al. · Cancer Medicine · 2023 · 37 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 14